Man Group PLC Guardant Health, Inc. Transaction History

Man Group PLC

$54.1 Billion
Q3 2025

A detailed history of Man Group PLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Man Group PLC holds 751,533 shares of GH stock, worth $70.9 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

751,533

Previous 806,072 6.77%

Holding current value

$70.9 Million

Previous $41.9 Million 11.94%

% of portfolio

0.09%

Previous 0.08%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$40.98 - $67.42 $2.24 Million - $3.68 Million	-54,539 Reduced 6.77%	751,533 $47 Million
Q2 2025 Aug 14, 2025	BUY	$37.05 - $52.04 $27.4 Million - $38.5 Million	739,800 Added 1116.31%	806,072 $41.9 Million
Q1 2025 May 15, 2025	SELL	$31.77 - $49.94 $27.3 Million - $42.9 Million	-859,036 Reduced 92.84%	66,272 $2.82 Million
Q4 2024 Feb 14, 2025	SELL	$20.2 - $38.11 $1.93 Million - $3.64 Million	-95,402 Reduced 9.35%	925,308 $28.3 Million
Q3 2024 Nov 14, 2024	BUY	$22.3 - $36.29 $22.8 Million - $37 Million	1,020,710 New	1,020,710 $23.4 Million

Q1 2024 May 15, 2024	SELL	$17.13 - $26.91 $628,551 - $987,408	-36,693 Reduced 3.64%	971,353 $20 Million
Q4 2023 Feb 14, 2024	BUY	$21.58 - $29.5 $8.63 Million - $11.8 Million	400,107 Added 65.81%	1,008,046 $27.3 Million
Q3 2023 Nov 14, 2023	BUY	$25.8 - $39.97 $15.3 Million - $23.7 Million	592,224 Added 3768.53%	607,939 $18 Million
Q2 2023 Aug 14, 2023	SELL	$20.94 - $38.01 $3.46 Million - $6.27 Million	-165,033 Reduced 91.31%	15,715 $562,000
Q1 2023 May 15, 2023	BUY	$22.92 - $33.76 $4.14 Million - $6.1 Million	180,748 New	180,748 $4.24 Million
Q2 2022 Aug 15, 2022	BUY	$28.82 - $77.35 $3.08 Million - $8.28 Million	107,026 Added 301.53%	142,520 $5.75 Million
Q1 2022 May 16, 2022	BUY	$48.25 - $100.49 $1.71 Million - $3.57 Million	35,494 New	35,494 $2.35 Million
Q4 2021 Feb 14, 2022	SELL	$88.71 - $120.43 $2.02 Million - $2.75 Million	-22,794 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$98.77 - $132.17 $1.77 Million - $2.36 Million	-17,878 Reduced 43.96%	22,794 $2.85 Million
Q2 2021 Aug 16, 2021	SELL	$109.77 - $165.68 $1.19 Million - $1.79 Million	-10,832 Reduced 21.03%	40,672 $5.05 Million
Q1 2021 May 17, 2021	BUY	$127.04 - $179.1 $469,793 - $662,311	3,698 Added 7.74%	51,504 $7.86 Million
Q4 2020 Feb 16, 2021	BUY	$99.96 - $135.93 $1.34 Million - $1.82 Million	13,422 Added 39.04%	47,806 $6.16 Million
Q3 2020 Nov 16, 2020	SELL	$80.32 - $111.8 $854,926 - $1.19 Million	-10,644 Reduced 23.64%	34,384 $3.84 Million
Q2 2020 Aug 14, 2020	BUY	$60.49 - $97.5 $2.46 Million - $3.96 Million	40,599 Added 916.66%	45,028 $3.65 Million
Q1 2020 May 15, 2020	BUY	$59.04 - $88.81 $261,488 - $393,339	4,429 New	4,429 $308,000
Q4 2019 Feb 18, 2020	SELL	$59.49 - $82.78 $453,908 - $631,611	-7,630 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$62.59 - $110.3 $129,310 - $227,879	2,066 Added 37.13%	7,630 $488,000
Q2 2019 Aug 14, 2019	SELL	$63.94 - $91.11 $195,272 - $278,249	-3,054 Reduced 35.44%	5,564 $480,000
Q1 2019 May 15, 2019	BUY	$34.3 - $97.98 $295,597 - $844,391	8,618 New	8,618 $661,000

Others Institutions Holding GH

# of Institutions

451

Shares Held

125M

Call Options Held

2.18M

Put Options Held

2.69M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $9.65B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account